Arterra Bioscience S.p.A.

ABS

IT0005386369

Biotechnology & Medical Research

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-07-12 am EDT			5-day change	1st Jan Change
2.14 ^EUR	-2.73%		-0.93%	+28.92%

Jul. 02	Futures bearish; Lagarde confirms caution	AN
Jul. 01	Mib and CAC the best after French vote	AN

Arterra Bioscience has purchased more than 26,000 of its own ordinary shares

October 13, 2023 at 02:02 pm EDT

(Alliance News) - Arterra Bioscience Spa reported Friday that it bought back 26,250 of its own ordinary shares between Oct. 9 and 13.

The shares were taken over at an average unit price of EUR1.7075, for a total consideration of EUR44,822.69.

To date, the company holds 116,300 treasury shares, representing 1.7 percent of its share capital.

Arterra Bioscience's stock closed Friday at par at EUR1.70 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Arterra Bioscience S.p.A.

Futures bearish; Lagarde confirms caution	Jul. 02	AN
Mib and CAC the best after French vote	Jul. 01	AN
Mib revises 33,500; MPS and BPER act as locomotive	Jul. 01	AN
Lists bullish; banks on top in Milan	Jul. 01	AN
Stock markets in green galvanized by inflation data	Jun. 28	AN
Markets bullish; MPS and Tenaris do well on Mib.	Jun. 28	AN
Arterra Bioscience S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Jun. 26	CI
Mib rises to 33,600; Azimut tops all	Jun. 20	AN
Stocks up before BoE; SNB cuts rate	Jun. 20	AN
Mib bearish; focus on quarterlies	May. 08	AN
Mib still in the green; Campari drags bullishness	May. 07	AN
Indices in green; Iren hurt after Ad shutdown	May. 07	AN
Stock markets up; results push UniCredit and Simone	May. 07	AN
Mib in green; UniCredit and MPS boost profit	May. 07	AN
Mib caresses 34,000; Amplifon bullish	May. 06	AN
Arterra Bioscience increases turnover by 26 percent in first quarter	May. 06	AN
ITALY GROWTH WINNERS & LOSERS: Askoll EVA rallying; Alfonsino trailing.	Apr. 24	AN
Arterra Bioscience with profit down; board confirms dividend	Apr. 02	AN
Futures down; China sets growth at 5 percent	Mar. 05	AN
Mib slightly down; still strength on Saipem	Mar. 04	AN
Mib opens higher, still good for banks	Feb. 23	AN
Arterra, decree consessione agevolzioni bando Rome Technopole	Feb. 15	AN
Arterra Bioscience closes 2023 with declining revenues	Feb. 13	AN
Banks weigh on Mib in the red	Feb. 13	AN
Futures down slightly; wait for U.S. CPI	Feb. 13	AN

Chart Arterra Bioscience S.p.A.

Duration

Period

More charts

Arterra Bioscience SpA is an Italy-based biotechnology company. It focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Companyâs main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The Company collaborates with private companies, universities and research institutes all over the world.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ARTERRA BIOSCIENCE S.P.A.	+28.92%	15.54M
MODERNA, INC.	+22.10%	46.55B
LONZA GROUP AG	+46.45%	41.84B
IQVIA HOLDINGS INC.	-3.12%	40.84B
ALNYLAM PHARMACEUTICALS, INC.	+36.10%	32.95B
CELLTRION, INC.	-6.30%	28.27B
ICON PUBLIC LIMITED COMPANY	+18.71%	27.78B
UNITED THERAPEUTICS CORPORATION	+46.15%	14.26B
MEDPACE HOLDINGS, INC.	+44.52%	13.69B
BIO-TECHNE CORPORATION	+0.19%	12.18B